Mengyu Zhang

419 Fang Xie Road
Shanghai, 200011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

TIM3 alleviates microglia-mediated neuroinflammation in neuropathic pain by negatively regulating glycolysis-driven NLRP3 inflammasome activation.

TIM3 alleviates microglia-mediated neuroinflammation in neuropathic pain by negatively regulating glycolysis-driven NLRP3 inflammasome activation.

Journal: Acta biochimica et biophysica Sinica

Published: July 01, 2026

The role of PCMT1 in prognosis tumor immune microenvironment and therapeutic responses across cancers.

The role of PCMT1 in prognosis tumor immune microenvironment and therapeutic responses across cancers.

Journal: Discover oncology

Published: August 19, 2025

Human endogenous retroviruses in schizophrenia: clinical evidence, molecular mechanisms, and implications.

Human endogenous retroviruses in schizophrenia: clinical evidence, molecular mechanisms, and implications.

Journal: Frontiers in cellular and infection microbiology

Published: July 31, 2025

The diagnostic potential of extracellular vesicles in virus-related diseases.

The diagnostic potential of extracellular vesicles in virus-related diseases.

Journal: Frontiers in cellular and infection microbiology

Published: June 05, 2025

The role of HERV envelope protein in ovarian cancer.

The role of HERV envelope protein in ovarian cancer.

Journal: Frontiers in cell and developmental biology

Published: April 26, 2025

Characteristics and potential predictors of prematurely terminated interventional clinical trials for ovarian cancer in the ClinicalTrials.gov database.

Characteristics and potential predictors of prematurely terminated interventional clinical trials for ovarian cancer in the ClinicalTrials.gov database.

Journal: BMC cancer

Published: July 22, 2024

Efficacy of PD-1 or PD-L1 inhibitors for the therapy of cervical cancer with varying PD-L1 expression levels: a single-arm meta-analysis.

Efficacy of PD-1 or PD-L1 inhibitors for the therapy of cervical cancer with varying PD-L1 expression levels: a single-arm meta-analysis.

Journal: Frontiers in oncology

Published: June 25, 2024

Human endogenous retroviruses and exogenous viral infections.

Human endogenous retroviruses and exogenous viral infections.

Journal: Frontiers in cellular and infection microbiology

Published: May 27, 2024

Combined aqupla, paclitaxel liposome, and docetaxel treatment: survival and biomarker outcomes in recurrent ovarian cancer patients.

Combined aqupla, paclitaxel liposome, and docetaxel treatment: survival and biomarker outcomes in recurrent ovarian cancer patients.

Journal: Frontiers in oncology

Published: April 23, 2024

Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer.

Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer.

Journal: Journal of ovarian research

Published: September 11, 2023

Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism.

Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism.

Journal: Journal of nanobiotechnology

Published: June 24, 2020

Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy.

Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy.

Journal: Drug delivery

Published: April 19, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026